AMELIA CASE: Open Payments
NPI 1942507603 · MAYNARDVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 73 payments from 18 companies in 2025. Trend: 2023 $1,309 · 2024 $1,504 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $211 |
| PFIZER INC. | 13 | $209 |
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| Antares Pharma, Inc. | 1 | $129 |
| Otsuka America Pharmaceutical, Inc. | 6 | $119 |
| Lundbeck LLC | 4 | $85 |
| Lilly USA, LLC | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Axsome Therapeutics, Inc. | 4 | $70 |
Products named: REXULTI, XYOSTED, UBRELVY, NURTEC ODT, ELIQUIS, BREZTRI, CAPLYTA, Auvelity.
Industry payments across TN — which companies pay providers there.
